Prognostic impact of syndecan-1 expression in invasive ductal breast carcinomas von Loussouarn, D, Campion, L, Sagan, C, Frenel, J-S, Dravet, F, Classe, J-M, Pioud-Martigny, R, Berton-Rigaud, D, Bourbouloux, E, Mosnier, J-F, Bataille, F-R, Campone, M

Volltext

Safety and pharmacokinetics of paclitaxel and the oral mTOR inhibitor everolimus in advanced solid tumours von Campone, M, Levy, V, Bourbouloux, E, Berton Rigaud, D, Bootle, D, Dutreix, C, Zoellner, U, Shand, N, Calvo, F, Raymond, E

Volltext

Evaluation of the safety of C-1311 (SYMADEX) administered in a phase 1 dose escalation trial as a weekly infusion for 3 consecutive weeks in patients with advanced solid tumours von Isambert, N, Campone, M, Bourbouloux, E, Drouin, M, Major, A, Yin, W, Loadman, P, Capizzi, R, Grieshaber, C, Fumoleau, P

Volltext

Brown fat in breast cancer patients: analysis of serial (18)F-FDG PET/CT scans von Rousseau, C, Bourbouloux, E, Campion, L, Fleury, N, Bridji, B, Chatal, J F, Resche, I, Campone, M

Volltext

Vinflunine: a new active drug for second-line treatment of advanced breast cancer. Results of a phase II and pharmacokinetic study in patients progressing after first-line anthracy... von CAMPONE, M, CORTES-FUNES, H, ASLANIS, V, FUMOLEAU, P, VOROBIOF, D, MARTIN, M, SLABBER, C. F, CIRUELOS, E, BOURBOULOUX, E, MENDIOLA, C, DELGADO, F. M, COLIN, C

Volltext

A phase I study of vinflunine in combination with capecitabine in patients with metastatic breast cancer previously treated with anthracyclines and taxanes von Campone, M., Isambert, N., Bourbouloux, E., Roché, H., Bonneterre, J., Milano, G., Fumoleau, P.

Volltext

3621 POSTER Assessing 2-month Clinical Prognosis in Patients With Solid Tumours – Final Results of PRONOPALL Study von Bourgeois, H, Traore, S, Maillard, P, Marcq, M, Boucher, E, Bourbouloux, E, Baudon, J, Mussault, P, Ingrand, P, Grude, F

Volltext

1886P Expectations and priorities of older patients with cancer: The PRIORITY multicenter cohort study von Grellety, T., Bellera, C., Cantarel, C., Mertens, C., Cabart, M., Roubaud, G., Chantecaille, M-C., Desclos, H., Lefort, A., Bouchaert, P., Bourbouloux, E., Terret, C., Delattre, C., Cany, L., Lalet, C., Mathoulin, S., Soubeyran, P., Chakiba Brugere, C.

Volltext

6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial von Kerbrat, Pierre, Fumoleau, Pierre, Jacquin, Jean-Philippe, Abadie-Lacourtoisie, Sophie, Cany, Laurent, Khayat, David, Paget-Bailly, Sophie, Demarchi, F, N'Guyen, T, Stein, U, Villanueva, C, Guimont, I, Lévy, E, Delbaldo, C, Pouessel, D, Fournel-Fédérico, C, Freyer, G, Tartas, S, Bons, F, Cuvier, C, Hajjaji, N, Capitain, O, Maillart, P, Bonnefoi, H, Durand, M, Madranges, N, Mauriac, L, Durando, X, Durieux, A, Piperno-Neumann, S, Tresca, P, Ferrant, E, Mayer, F, Vanneuville, AC, Servent, V, Guastalla, JP, Biron, P, Dupuy-Brousseau, L, Lancry, L, Trédan, O, Extra, JM, Berton-Rigaud, D, Ferrero, JM, Largillier, R, Gedoin, D, Laguerre, B, Lefeuvre, C, Vauléon, E, Tennevet, I, Mefti-Lacheraf, F, Dalenc, F, André, F, Domont, J, Ezenfis, J, Provençal, J, Bellaiche-Miccio, C, Boutan-Laroze, G, Arsène, O, Merad-Boudia, Z, Orfeuvre, H, Lamy, R, Sarda, C, Salles, B, Cauvin, I, Mangold, M, Bourcier, A, Geay, JF, ElAmarti, R, Combe, M, Dauba, J, Denizon, N, Clavreul, G, Goubely, Y, Delecroix, V, Ligeza-Poisson, V, Leyronnas, C, Teissier, E, Bernard, O, Pottier-Kyndt, V, Drony, S, Moriceau, M, Besson, D, Achille, E, Moran-Ribon, A, Moullet, I, Couderc, B, Burki, F, Schaeffer, F, Montcuquet, P, Baumont, GA, Gréget, S, Ratoanina, JL, Bonichon-Lamichhane, M, Cartron, G, Dupuis, O, Ganem, G, LeRol, A, Antoine, EC, Llory, JF, Loiseau, D

Volltext

6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial von Pivot, Xavier, Prof, Romieu, Gilles, MD, Debled, Marc, MD, Pierga, Jean-Yves, Prof, Kerbrat, Pierre, Prof, Bachelot, Thomas, MD, Lortholary, Alain, MD, Espié, Marc, MD, Fumoleau, Pierre, Prof, Serin, Daniel, MD, Jacquin, Jean-Philippe, MD, Jouannaud, Christelle, MD, Rios, Maria, MD, Abadie-Lacourtoisie, Sophie, MD, Tubiana-Mathieu, Nicole, Prof, Cany, Laurent, MD, Catala, Stéphanie, MD, Khayat, David, Prof, Pauporté, Iris, PhD, Kramar, Andrew, PhD

Volltext

1680P Feasibility of home-based supervised physical activity (SPA) for metastatic cancer patients receiving oral targeted therapy: The AFSOS-Unicancer QUALIOR randomized phase II s... von Lobbedez, F. Joly, Lefeuvre-Plesse, C., Charton, E., Helissey, C., Priou, F., Stefani, L., Simmet, V., Garnier-Tixidre, C., Meneveau, N., Houede, N., Salas, S., Bourbouloux, E., Descotes, J-M., Anota, A., Nenan, S., Rieger, I.

Volltext

A rare gynecological case of paraneoplastic cerebellar degeneration discovered by FDG-PET von Marchand, V, Graveleau, J, Lanctin-Garcia, C, Bourbouloux, E, Bridji, B, Resche, I, Kraeber-Bodéré, F, Rousseau, C

Volltext

Lapatinib in metastatic breast cancer von Frenel, J-S, Bourbouloux, Berton-Rigaud, Sadot-Lebouvier, Zanetti, Campone

Volltext

ASTER 70s UNICANCER phase III Trial: Can a genomic prognosticator help tailoring adjuvant systemic treatment for luminal breast carcinoma in elderly women? von Dubot, C, Bourbouloux, E, Mir, O, Kirscher, S, Rigal, O, Ferrero, J.-M, Curé, H, Blot, E, Allouache, D, Cottu, P, Romieu, G, Lefeuvre, C, Malaurie, E, Tubiana-Mathieu, N, Lacroix-Triki, M, Rollot, F, Peyro-Saint-Paul, H, Orsini, C, Bonnetain, F, Brain, E

Volltext

Adjuvant chemotherapy for luminal breast cancer in elderly women: Feasibility of the ongoing ASTER 70S gerico UNICANCER phase III trial von Bourbouloux, E, Tazi, Y, Cure, H, Ferrero, J.-M, RIgal, O, Romieu, G, Rollot-trad, F, Lacroix-triki, M, Peyro-saint-paul, H, Orsini, C, Bonnetain, F, Brain, E

Volltext

125P Cognitive impairment in breast cancer patients up to 18 months after cancer treatments: The French multicentric longitudinal CANTO-Cog cohort substudy von Lobbedez, F. Joly, Hardy-Léger, I., Arbogast, S. Lefevre, Rigal, O., Le Fel, J., Pistilli, B., Petrucci, J., Lévy, C., Capel, A., Coutant, C., Lerebours, F., Vanlemmens, L., Bourbouloux, E., Vaz-Luis, I., Martin, A-L., Everhard, S., André, F., Charles, C., Dauchy, S., Lange, M.

Volltext

SIOG2024-3-OA-028 Expectations and priorities of older patients with cancer: the PRIORITY multicenter cohort study von Chakiba, C., Bellera, C., Cantarel, C., Mertens, C., Cabart, M., Roubaud, G., Bijou, F., Chantecaille, M.-C., Desclos, H., Botin, T., Bouchaert, P., Bourbouloux, E., Terret, C., Delattre, C., Cany, L., Lalet, C., Mathoulin-Pélissier, S., Soubeyran, P., Grellety, T.

Volltext

Brown fat in breast cancer patients: analysis of serial 18F-FDG PET/CT scans von Rousseau, C., Bourbouloux, E., Campion, L., Fleury, N., Bridji, B., Chatal, J. F., Resche, I., Campone, M.

Volltext

Phase i dose-escalation study of a novel antitumor agent, SR271425, administered intravenously in split doses (dl-d2-d3) in patients with refractory solid tumors von CAMPONE, M, ISAMBERT, N, BOURBOULOUX, E, MAURY, S, MONIN-BAROILLE, P, BERILLE, J, FUMOLEAU, P

Volltext

Doxorubin-based adjuvant chemotherapy for elderly patients with hormone receptors negative breast carcinoma: a French geriatric oncology group (GERICO) phase II multicentric progra... von Debled, M, Girre, V, Mertens, C, Blot, E, Rousseau, F, Abadie, S, Uwer, L, Bourbouloux, E, Fourme, E, Gouttenoire, F, Brain, E

Volltext